BioSpace News Archive

New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization

Equifund CFP, an equity crowdfunding platform that delivers vetted, early-stage investment opportunities, announces one of its Issuers, Biopact Cellular Transport Inc., has signed a major partnership with a leading biotechnology company.

As the COVID-19 pandemic remains entrenched in the United States, demand for effective and comfortable face masks continues to climb. To meet the current and future needs, Creative Home Ideas/YMF, an American company with 35 years of experience in developing and manufacturing, has launched a new division, Germ Tech,

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported second quarter 2020 financial results and provided a business update.

BioLife Solutions, Inc., a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, announced financial results for the three and six months ended June 30, 2020.

PDL BioPharma, Inc. reports financial results for the three and six months ended June 30, 2020 and provides an update on important milestones achieved in the execution of its monetization plan

“We achieved record net sales of $15.3 million in the second quarter while maintaining our focus on the science, announcing our 200th research agreement and tenth published human trial on Niagen®,” says ChromaDex CEO Rob Fried.

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and six months ended June 30, 2020 and provides a business update.

Cutera, Inc., a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, reported financial results for the second quarter ended June 30, 2020.

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, reported its financial results for second quarter ended June 30, 2020 and provided a corporate update.